欧洲给药系统市场至 2027 年 - 按给药途径（经粘膜、口服、注射、局部、植入和眼部）进行区域分析和预测；分销渠道（医院药房、零售药房、网上药房）；和应用（家庭护理场所、医院和诊所等）和地理位置
No. of Pages: 235 | Report Code: TIPRE00005753 | Category: Life Sciences
No. of Pages: 235 | Report Code: TIPRE00005753 | Category: Life Sciences
欧洲给药系统市场预计将从 2018 年的 343,533.9 美元增至 2027 年的 610,320.4 百万美元。预计从 2019 年开始，该市场将以 6.7% 的复合年增长率增长 - 2027年。
药企投资增加、医疗器械等因素设备公司的研发和欧洲慢性疾病的兴起预计将促进欧洲药物输送系统市场的增长。另一方面，欧洲制造商对给药系统的监管召回可能会在一定程度上对市场增长产生负面影响。
<具有更有效功效的创新技术产品是治疗各种慢性疾病的主要要求。在过去几年中，治疗的进步和发展不断增加。随着欧洲地区慢性病患病率的增加，对更多先进产品的需求也在增加。因此，多年来，研究人员一直在开展研究活动，并带来了产品创新。
例如，2018年7月，罗氏因其创新的 Accu-Chek Solo 微型泵系统获得了 CE 标志。该系统是一种小型无管胰岛素输送装置，为用户提供直接从泵进行推注的选择。该系统是一个功能齐全的手持设备，包括泵的拆卸和重新连接功能，而不浪费胰岛素。 Accu-Chek Solo 微型泵与罗氏的数字健康解决方案相结合，为用户提供更有效和个性化的糖尿病管理。因此，药物输送系统的创新很可能成为未来几年全球药物输送系统市场的普遍趋势。
欧洲药物输送系统——市场细分
按给药途径
按申请
按
分销渠道
按国家/地区
提及的公司
Strategic insights for Europe Drug Delivery Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 343,533.9 Million |
| Market Size by 2027 | US$ 610,320.4 Million |
| Global CAGR (2019 - 2027) | 6.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 给药途径
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Drug Delivery Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Drug Delivery Systems Market is valued at US$ 343,533.9 Million in 2018, it is projected to reach US$ 610,320.4 Million by 2027.
As per our report Europe Drug Delivery Systems Market, the market size is valued at US$ 343,533.9 Million in 2018, projecting it to reach US$ 610,320.4 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
The Europe Drug Delivery Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Drug Delivery Systems Market report:
The Europe Drug Delivery Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Drug Delivery Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Drug Delivery Systems Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Drug Delivery Systems Market
